» Articles » PMID: 21925301

How Mitotic Errors Contribute to Karyotypic Diversity in Cancer

Overview
Journal Adv Cancer Res
Publisher Elsevier
Specialty Oncology
Date 2011 Sep 20
PMID 21925301
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Aneuploidy is a common feature of cancer cells, and is believed to play a critical role in tumorigenesis and cancer progression. Most cancer cells also exhibit high rates of mitotic chromosome mis-segregation, a phenomenon known as chromosomal instability, which leads to high variability of the karyotype. Here, we describe the nature, nuances, and implications of cancer karyotypic diversity. Moreover, we summarize recent studies aimed at identifying the mitotic defects that may be responsible for inducing chromosome mis-segregation in cancer cells. These include kinetochore attachment errors, spindle assembly checkpoint dysfunction, mitotic spindle defects, and other cell division inaccuracies. Finally, we discuss how such mitotic errors generate karyotypic diversity in cancer cells.

Citing Articles

CCNA2 and NEK2 regulate glioblastoma progression by targeting the cell cycle.

Zhou H, Wang Y, Wang T, Wu W, Cao Y, Zhang B Oncol Lett. 2024; 27(5):206.

PMID: 38516683 PMC: 10956385. DOI: 10.3892/ol.2024.14339.


A DNA-PK phosphorylation site on MET regulates its signaling interface with the DNA damage response.

Koch J, Roth S, Quintin A, Gavini J, Orlando E, Riedo R Oncogene. 2023; 42(26):2113-2125.

PMID: 37188738 PMC: 10289896. DOI: 10.1038/s41388-023-02714-6.


Identification of Five m6A-Related lncRNA Genes as Prognostic Markers for Endometrial Cancer Based on TCGA Database.

Shan L, Lu Y, Xiang C, Zhu X, Zuo E, Cheng X J Immunol Res. 2022; 2022:2547029.

PMID: 35571565 PMC: 9095403. DOI: 10.1155/2022/2547029.


Genome doubling causes double trouble.

Eliezer Y, Ben-David U Nature. 2022; 604(7904):44-45.

PMID: 35354975 DOI: 10.1038/d41586-022-00849-2.


Use of 6 m6A-relevant lncRNA genes as prognostic markers of primary liver hepatocellular carcinoma based on TCGA database.

Zhu X, Li Q, Shen J, Shan L, Zuo E, Cheng X Transl Cancer Res. 2022; 10(12):5337-5351.

PMID: 35116381 PMC: 8797289. DOI: 10.21037/tcr-21-2440.